Impact of body mass index on estradiol depletion by aromatase inhibitors in postmenopausal women with early breast cancer

BACKGROUND: Body mass index (BMI) has an impact on survival outcome in patients treated with aromatase inhibitors (AIs). Obesity is associated with an increased body aromatisation and may be a cause of insufficient estradiol depletion. METHODS: Sixty-eight postmenopausal oestrogen receptor-positive...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Pfeiler, G, Königsberg, R, Hadji, P, Fitzal, F, Maroske, M, Dressel-Ban, G, Zellinger, J, Exner, R, Seifert, M, Singer, C, Gnant, M, Dubsky, P
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2013
Matèries:
Clinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3777005/
https://ncbi.nlm.nih.gov/pubmed/24002592
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2013.499
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars